Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – DOVA, VSI, PRTO

10/22, 9:11 PM (Source: GlobeNewswire)

NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Dova Pharmaceuticals, Inc. (NASDAQ: DOVA)
The investigation concerns whether Dova and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Dova to Swedish Orphan Biovitrum AB. Under the terms of the agreement, Dova shareholders will be offered an upfront payment for $27.50 per share in cash and one non-tradeable Contingent Value Right to an additional $1.50 per share in cash upon regulatory approval of DOPTELET. If you are a Dova shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/dova-pharmaceuticals-inc-sobi-stock-merger-swedish/.

Vitamin Shoppe, Inc. (NYSE: VSI)
The investigation concerns whether Vitamin Shoppe and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Vitamin Shoppe to Liberty Tax, Inc. for $6.50 per share. If you are a Vitamin Shoppe shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/vitamin-shoppe-inc-vsi-stock-merger-liberty-tax/.

Proteon Therapeutics, Inc. (NASDAQ: PRTO)
The investigation concerns whether Proteon and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed merger between Proteon and ArTara Therapeutics, Inc. in an all-stock transaction. If you are a Proteon shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/proteon-therapeutics-inc-prto-stock-merger-artara-therapeutics/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Primary Logo

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.